Cargando…
After 25 years of drug development, do we know JAK?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280879/ https://www.ncbi.nlm.nih.gov/pubmed/35831034 http://dx.doi.org/10.1136/rmdopen-2022-002409 |
| _version_ | 1784746748870131712 |
|---|---|
| author | Mortezavi, Mahta Martin, David A Schulze-Koops, Hendrik |
| author_facet | Mortezavi, Mahta Martin, David A Schulze-Koops, Hendrik |
| author_sort | Mortezavi, Mahta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9280879 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92808792022-07-28 After 25 years of drug development, do we know JAK? Mortezavi, Mahta Martin, David A Schulze-Koops, Hendrik RMD Open Rheumatoid Arthritis BMJ Publishing Group 2022-07-13 /pmc/articles/PMC9280879/ /pubmed/35831034 http://dx.doi.org/10.1136/rmdopen-2022-002409 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Rheumatoid Arthritis Mortezavi, Mahta Martin, David A Schulze-Koops, Hendrik After 25 years of drug development, do we know JAK? |
| title | After 25 years of drug development, do we know JAK? |
| title_full | After 25 years of drug development, do we know JAK? |
| title_fullStr | After 25 years of drug development, do we know JAK? |
| title_full_unstemmed | After 25 years of drug development, do we know JAK? |
| title_short | After 25 years of drug development, do we know JAK? |
| title_sort | after 25 years of drug development, do we know jak? |
| topic | Rheumatoid Arthritis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280879/ https://www.ncbi.nlm.nih.gov/pubmed/35831034 http://dx.doi.org/10.1136/rmdopen-2022-002409 |
| work_keys_str_mv | AT mortezavimahta after25yearsofdrugdevelopmentdoweknowjak AT martindavida after25yearsofdrugdevelopmentdoweknowjak AT schulzekoopshendrik after25yearsofdrugdevelopmentdoweknowjak |